Vaccine Overview
Rotavirus Vaccine, (Live Attenuated Oral), (Liquid)
The Rotavirus Vaccine (Live Attenuated Oral) I.P. (Oral) is an oral vaccine designed to protect against rotavirus, a leading cause of gastroenteritis in infants and young children. Administered orally, this vaccine is available as a liquid formulation. It is given in a series of two or three doses starting at 6-8 weeks of age, with subsequent doses spaced about 4-6 weeks apart. The vaccine significantly reduces the risk of severe diarrhea, vomiting, and dehydration caused by rotavirus infections.
Drug Class: Viral Vaccines
Indication: ROTASIIL-Liquid is indicated for active immunization of healthy infants from the age of 6 weeks for the prevention of gastroenteritis due to rotavirus infection when administered as a 3-dose series. The three-dose regimen should be completed by one year of age.
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
First dose at 6–8 weeks, second dose at 4–6 weeks after first dose, third dose (if applicable) at 14–16 weeks
Administration
Route: ROTASIIL-Liquid is for ORAL ADMINISTRATION ONLY AND MUST NOT BE ADMINISTERED PARENTERALLY
Site: Administered orally as a liquid directly into the infant’s mouth (no injection site)
Disease
Rotavirus
Manufacturer
Serum Intitute Of India
Age
- Infants (6–16 weeks)
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025